Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) shares reached a new 52-week low on Tuesday . The company traded as low as $26.57 and last traded at $26.73, with a volume of 291079 shares traded. The stock had previously closed at $27.67. Analyst Upgrades and Downgrades A number of research firms have issued reports […]
Pacira BioSciences (NASDAQ:PCRX – Get Free Report) is set to release its earnings data before the market opens on Thursday, November 2nd. Analysts expect Pacira BioSciences to post earnings of $0.84 per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link. Pacira BioSciences […]
Hussman Strategic Advisors Inc. trimmed its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 44.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 26,000 shares of the company’s stock after selling 20,800 shares during the period. Hussman […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) has received an average rating of “Moderate Buy” from the nine brokerages that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12 month […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) has been given an average rating of “Moderate Buy” by the nine analysts that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12 month price […]